Why Genetic Testing is Critical for Managing Neurological Disorders

Genetic testing for neurological disorders involves analyzing an individual's DNA to identify genetic variations that may contribute to or cause a neurological condition. The types of genetic testing available include diagnostic testing, which looks for specific genetic mutations known to cause a particular disorder, and predictive testing, which assesses an individual's risk of developing a condition based on their genetic makeup. Genetic testing can also be used for carrier testing to determine if an individual carries a genetic mutation that could be passed on to their children.

With care for you

In some cases, genetic testing may not provide a clear diagnosis, but it can help narrow down the possible causes of a neurological condition and inform treatment options. It is important to note that genetic testing is not always necessary or appropriate for every neurological disorder, and it should be carefully considered in consultation with a healthcare provider or genetic counselor.

75% Remain undiagnosed

Benefits Of Genetic Testing

Early diagnosis

Genetic testing can detect mutations linked to neurological disorders before symptoms appear, enabling early diagnosis and better outcomes.

Accurate diagnosis

Genetic testing can help to confirm a diagnosis, especially when symp- toms are non-specific or when there is uncertainty about the underlying cause of the disorder.

Personalized treatment

Genetic testing identifies mutations that may respond better to specific treatments, enabling personalized care tailored to each patient.

Family planning

Genetic testing for neurological disorders helps assess the risk of passing these conditions to children, supporting family planning.

Prognostic information

Genetic testing can provide prognostic information about the likely course of the disorder, which can help patients and their families prepare for the future.

Clinical trials

Genetic testing can identify patients who may be eligible for clinical trials of new treatments, which can provide access to novel therapies that may improve outcomes.

Gene List

ADNP, AFF2, ALDH7A1, ANG, APTX, ARX, ASPA, ASXL1, ATN1, ATP1A2, ATP7B, ATXN1, ATXN10, ATXN2, ATXN3, ATXN7, ATXN8OS, BCL11A, BSCL2, C12orf4, CACNA1A, CACNA1C, CC2D1A, CDKL5, CHD2, CNOT3, CNTN6, COL4A1, COL4A3BP, CSNK2A1, CSTB, CTNND2, DHCR7, DPYD, EGR2, EHMT1, EN2, EZH2, FBXO11, FMR1, FOXG1, FOXP1, FTSJ1, FXN, GABRG2, GAMT, GARS, GATM, GBA, GCH1, GRIN2A, GRN, HEXA, HFE, HSPB1, HTT, IKBKAP, KCNQ2, KDM5C, L1CAM, LRRK2, MAPT, MBOAT7, MECP2, MED12, MTHFR, MTM1, NDP, NDUFA1, NLGN3, NLGN4X, NOTCH3, NSD1, NTRK1, NTRK2, PABPN1, PCDH19, PDGFB, PDHA1, PIK3CA, PINK1, PMP22, PNKD, POLG, PPP2R2B, PRRT2, PSEN1, PTEN, REEP1, SCN1A, SCN1B, SCN2A, SCN8A, SCO2, SGCE, SLC16A2, SLC2A1, SLC6A8, SLC9A6, SMN1, SMN2, SOD1, SPG11, STXBP1, SYNGAP1, TARDBP, TBP, TCF4, TH, THAP1, TOR1A, TPP1, TSC1, TSC2, TTR, UBA1, ZEB2, ZNF41, ACADM, APOE, APP, ARSA, ATM, BCKDHA, BCKDHB, BCS1L, BLM, C10orf2, COQ2, COX10, DGUOK, ERBB4, FANCC, FUS, G6PC, GAA, GALT, GBE1 , GJB1 , HBB , MCOLN1, MFN2 , MPV17 , MPZ , NPC1 , OPA1 , OPTN , PAH , PDSS2 , PLCG2 , POLG2 , PRNP , PSEN2 , RRM2B, SCO1 , SETX , SLC25A4 , SPAST , SPTLC1 , SUCLA2 , SUCLG1 , TAZ , TK2 , TYMP.

Test Specifications

This panel may be appropriate for anyone who has a personal or family history of frequent infections, fevers, or rash, particularly if infections do not completely clear up or keep coming back, require hospitalization or IV antibiotics, or are caused by an uncommon organism

Acceptable Sample Requirements

Buccal swab or saliva

Reporting

Likely pathogenic and pathogenic variants

Turnaround Time

2-3 weeks Coverage _>96% at 20x

Customization

Customizable gene list

What To Do When Genetic Testing Comes Back Positive

Doctors may confirm the diagnosis
1.
Confirm the diagnosis

If a genetic mutation is identified, doctors may confirm the diagnosis through further testing or clinical evaluation to determine the extent of the disease or condition.

Test results will be sent to your personal email
2.
Update the patient and family.

The doctor will inform the patient and family about the diagnosis and genetic test results, including the option for genetic counseling.

An individual treatment plan is developed based on the diagnosis
3.
Develop a treatment plan

The doctor will develop a treatment plan tailored to the specific disorder and the patient's individual needs. This may include medications, therapies, and lifestyle changes.

The treatment plan may be adjusted if the body does not respond.
4.
Monitor the patient

The doctor will monitor the patient's condition and adjust treatment as necessary. Refer the patient and family to a genetic counselor for risk discussion and family planning.

Have question you don’t see on here? Write us!

We will be happy to answer your questions